Literature DB >> 33757446

Post treatment quality of life among Sri Lankan women with breast cancer.

Ravindri Jayasinghe1, Ashan Fernando1, Umesh Jayarajah2, Sanjeewa Seneviratne1.   

Abstract

BACKGROUND: Breast cancer and its treatment imposes a significant effect in the quality of life (QOL) of women. Being a developing country with contrasting social and cultural norms to the West, Sri Lankan women may have a different experience on QOL following surgical treatment of breast cancer. This study was conducted to evaluate post-treatment QOL in breast cancer patients and to determine its association with the type of surgery.
METHODS: A cross sectional study was carried out. Fifty four women with non-metastatic breast cancer who underwent surgery for breast cancer at the Professorial Surgical Unit, Colombo during 2015-2018 and completed a minimum of one year follow up after surgery were invited to participate. Fifty-four women who responded were assessed using the validated EORTC QLQ-C30 and QLQ-BR23 questionnaires. Non-parametric tests were used for statistical analyses.
RESULTS: The mean age was 59 years (range 36-81). A majority (61%, n = 35) underwent mastectomy and the rest (n = 19, 45%) breast conservation surgery (BCS). The mean QLQ-C30 score was 68.8 (range 8.3-100) and the mean scores for physical function, role function, emotional function, cognitive function, and social function were 71.4, 81.5, 77.0, 80.2, and 86.4, respectively. The mean scores for body image, sexual functioning, sexual enjoyment, future perspective, systemic therapy, breast symptoms, arm symptoms, and hair loss assessed by the QLQ-BR23 were 76.4, 18.3, 33.3, 73.6, 30.5, 16.2, 23.4 and 32.7, respectively. No significant differences (P > 0.05) were noted in global health status, physical function, role function, emotional function, cognitive function and social function between BCS and mastectomy. QLQ-BR23 body image, sexual functioning, sexual enjoyment and future perspective also did not differ significantly (p > 0.05) between the two groups.
CONCLUSIONS: Sexual functioning and enjoyment, breast and arm symptoms and hair loss contributed to poor QOL while the impact on global health status including physical, social and emotional functions were minimal. Type of surgery did not appear to be associated with QOL. Future studies with a larger sample sizes will be helpful to further study these factors.

Entities:  

Keywords:  Breast cancer; Breast-conserving surgery; Mastectomy; Quality of life; Sri Lanka

Mesh:

Year:  2021        PMID: 33757446      PMCID: PMC7988899          DOI: 10.1186/s12885-021-08055-5

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  17 in total

Review 1.  The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review.

Authors:  G M Kiebert; J C de Haes; C J van de Velde
Journal:  J Clin Oncol       Date:  1991-06       Impact factor: 44.544

2.  The association between complications and quality of life after mastectomy and breast reconstruction for breast cancer.

Authors:  John P Browne; Ranjeet Jeevan; Carmel Gulliver-Clarke; Jerome Pereira; Christopher M Caddy; Jan H P van der Meulen
Journal:  Cancer       Date:  2017-05-17       Impact factor: 6.860

3.  Comparison of quality of life, satisfaction with surgery and shoulder-arm morbidity in breast cancer survivors submitted to breast-conserving therapy or mastectomy followed by immediate breast reconstruction.

Authors:  Renata Freitas-Silva; Délio Marques Conde; Ruffo de Freitas-Júnior; Edson Zangiacomi Martinez
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

4.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

5.  Quality of life in cancer patients in South Asia: psychometric properties of the Sinhala version of the EORTC QLQ-C30 in cancer patients with heterogeneous diagnoses.

Authors:  Harindra Jayasekara; Lalini C Rajapaksa; Neil K Aaronson
Journal:  Qual Life Res       Date:  2008-04-22       Impact factor: 4.147

6.  Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women.

Authors:  Eileen M Kesson; Gwen M Allardice; W David George; Harry J G Burns; David S Morrison
Journal:  BMJ       Date:  2012-04-26

7.  Quality of Life Differences between Younger and Older Breast Cancer Patients.

Authors:  Byeong-Woo Park; Suyun Lee; Ah Reum Lee; Kyung-Hi Lee; Sook Yeon Hwang
Journal:  J Breast Cancer       Date:  2011-06-18       Impact factor: 3.588

Review 8.  Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies.

Authors:  Mohamed I Nounou; Fatema ElAmrawy; Nada Ahmed; Kamilia Abdelraouf; Satyanarayana Goda; Hussaini Syed-Sha-Qhattal
Journal:  Breast Cancer (Auckl)       Date:  2015-09-27

9.  Incidence trends and patterns of breast cancer in Sri Lanka: an analysis of the national cancer database.

Authors:  Ashan Fernando; Umesh Jayarajah; Saumyakala Prabashani; Eshani A Fernando; Sanjeewa A Seneviratne
Journal:  BMC Cancer       Date:  2018-04-27       Impact factor: 4.430

10.  Quality of life and symptom burden in patients with breast cancer treated with mastectomy and lumpectomy.

Authors:  Ronald Chow; Natalie Pulenzas; Liying Zhang; Christine Ecclestone; Angela Leahey; Julia Hamer; Carlo DeAngelis; Gillian Bedard; Rachel McDonald; Anchal Bhatia; Janet Ellis; Eileen Rakovitch; Sherlyn Vuong; Edward Chow; Sunil Verma
Journal:  Support Care Cancer       Date:  2015-11-13       Impact factor: 3.359

View more
  1 in total

1.  Quality of Life in Patients with Breast Cancer following Breast Conservation Surgery: A Systematic Review and Meta-Analysis.

Authors:  Yue Li; Jianming Guo; Yuan Sui; Baihui Chen; Dalin Li; Jiakang Jiang
Journal:  J Healthc Eng       Date:  2022-01-31       Impact factor: 2.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.